RESUMEN
BACKGROUND: The Gran Chaco ecoregion is a well-known hotspot of several neglected tropical diseases (NTDs) including Chagas disease, soil-transmitted helminthiasis and multiparasitic infections. Interspecific interactions between parasite species can modify host susceptibility, pathogenesis and transmissibility through immunomodulation. Our objective was to test the association between human co-infection with intestinal parasites and host parasitaemia, infectiousness to the vector and immunological profiles in Trypanosoma cruzi-seropositive individuals residing in an endemic region of the Argentine Chaco. METHODS: We conducted a cross-sectional serological survey for T. cruzi infection along with an intestinal parasite survey in two adjacent rural villages. Each participant was tested for T. cruzi and Strongyloides stercoralis infection by serodiagnosis, and by coprological tests for intestinal parasite detection. Trypanosoma cruzi bloodstream parasite load was determined by quantitative PCR (qPCR), host infectiousness by artificial xenodiagnosis and serum human cytokine levels by flow cytometry. RESULTS: The seroprevalence for T. cruzi was 16.1% and for S. stercoralis 11.5% (n = 87). We found 25.3% of patients with Enterobius vermicularis. The most frequent protozoan parasites were Blastocystis spp. (39.1%), Giardia lamblia (6.9%) and Cryptosporidium spp. (3.4%). Multiparasitism occurred in 36.8% of the examined patients. Co-infection ranged from 6.9% to 8.1% for T. cruzi-seropositive humans simultaneously infected with at least one protozoan or helminth species, respectively. The relative odds of being positive by qPCR or xenodiagnosis (i.e. infectious) of 28 T. cruzi-seropositive patients was eight times higher in people co-infected with at least one helminth species than in patients with no such co-infection. Trypanosoma cruzi parasite load and host infectiousness were positively associated with helminth co-infection in a multiple regression analysis. Interferon-gamma (IFN-γ) response, measured in relation to interleukin (IL)-4 among humans infected with T. cruzi only, was 1.5-fold higher than for T. cruzi-seropositive patients co-infected with helminths. The median concentration of IL-4 was significantly higher in T. cruzi-seropositive patients with a positive qPCR test than in qPCR-negative patients. CONCLUSIONS: Our results show a high level of multiparasitism and suggest that co-infection with intestinal helminths increased T. cruzi parasitaemia and upregulated the Th2-type response in the study patients.
Asunto(s)
Enfermedad de Chagas , Coinfección , Helmintiasis , Parasitosis Intestinales , Trypanosoma cruzi , Humanos , Trypanosoma cruzi/inmunología , Trypanosoma cruzi/genética , Trypanosoma cruzi/aislamiento & purificación , Coinfección/parasitología , Coinfección/epidemiología , Coinfección/inmunología , Enfermedad de Chagas/epidemiología , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/parasitología , Enfermedad de Chagas/sangre , Enfermedad de Chagas/inmunología , Animales , Adulto , Estudios Transversales , Masculino , Femenino , Parasitosis Intestinales/epidemiología , Parasitosis Intestinales/parasitología , Parasitosis Intestinales/complicaciones , Parasitosis Intestinales/inmunología , Persona de Mediana Edad , Helmintiasis/complicaciones , Helmintiasis/parasitología , Helmintiasis/epidemiología , Helmintiasis/inmunología , Adulto Joven , Adolescente , Argentina/epidemiología , Estudios Seroepidemiológicos , Strongyloides stercoralis/inmunología , Strongyloides stercoralis/aislamiento & purificación , Parasitemia/parasitología , Parasitemia/epidemiología , Células Th2/inmunología , Niño , Estrongiloidiasis/epidemiología , Estrongiloidiasis/parasitología , Estrongiloidiasis/complicaciones , Estrongiloidiasis/inmunología , Estrongiloidiasis/sangre , Anciano , Citocinas/sangre , Anticuerpos Antiprotozoarios/sangreRESUMEN
Immunosuppressed patients, particularly transplant recipients, can develop severe strongyloidiasis. This study aimed to detect anti-Strongyloides IgG antibodies in a panel of sera from liver transplant patients. Two techniques were used: ELISA as the initial screening test and Western blotting as a confirmatory test. ELISA reactivity of 10.9% (32/294) was observed. The 40-30 kDa fraction was recognised in 93.7% (30/32) of the patients, resulting in a positivity rate of 10.2%. These data highlight the importance of serological screening for Strongyloides stercoralis infection in liver transplant recipients.
Asunto(s)
Anticuerpos Antihelmínticos , Ensayo de Inmunoadsorción Enzimática , Inmunoglobulina G , Trasplante de Hígado , Strongyloides stercoralis , Estrongiloidiasis , Receptores de Trasplantes , Humanos , Estrongiloidiasis/diagnóstico , Estrongiloidiasis/inmunología , Estrongiloidiasis/sangre , Anticuerpos Antihelmínticos/sangre , Animales , Strongyloides stercoralis/inmunología , Inmunoglobulina G/sangre , Western Blotting , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Femenino , Adulto , Enfermedades Desatendidas/diagnóstico , Enfermedades Desatendidas/epidemiología , Enfermedades Desatendidas/inmunología , Huésped Inmunocomprometido , AncianoRESUMEN
A lateral flow rapid test for strongyloidiasis will greatly facilitate the control and elimination of the disease. Previously SsRapid prototype rapid test showed high diagnostic specificity to detect Strongyloides infection, determined using non-Strongyloides sera negative by IgG-ELISAs. Since high specificity is crucial before a test is used for public health control activities, further validation of its specificity is needed. Also, it needs to be ascertained whether non-Strongyloides sera positive by IgG-ELISAs and SsRapid are truly positive for Strongyloides or are cases of cross-reactivity. We performed 84 rapid tests (two types of dipsticks and cassettes) using 34 serum samples. They were divided into four groups based on Strongyloides infection and coinfection with other parasites and the availability of recombinant proteins and rapid tests for the latter. Sera was adsorbed using polystyrene microspheres beads separately coated with four recombinant parasite proteins. The small sample size is a limitation of this study; however, the overall results showed that the sera adsorption procedure was successful, and the SsRapid test is specific.
Asunto(s)
Adsorción , Anticuerpos Antihelmínticos/sangre , Anticuerpos Antihelmínticos/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina G/inmunología , Estrongiloidiasis/sangre , Estrongiloidiasis/inmunología , Animales , Humanos , Malasia , Sensibilidad y Especificidad , Pruebas Serológicas , Strongyloides stercoralis/aislamiento & purificaciónRESUMEN
BACKGROUND: The diagnosis of strongyloidiasis is challenging. Serological tests are acknowledged to have high sensitivity, but issues due to cross-reactions with other parasites, native parasite antigen supply and intrinsic test variability do occur. Assays based on recombinant antigens could represent an improvement. The aim of this study was to assess the sensitivity and specificity of two novel immunoglobulin (Ig)G and IgG4 enzyme-linked immunosorbent assays (ELISAs) based on the recombinant antigens NIE/SsIR for the diagnosis of strongyloidiasis. METHODS: This was a retrospective diagnostic accuracy study. We included serum samples collected from immigrants from strongyloidiasis endemic areas for whom there was a matched result for Strongyloides stercoralis on agar plate culture and/or PCR assay, or a positive microscopy for S. stercoralis larvae. For the included samples, results were also available from an in-house indirect fluorescent antibody test (IFAT) and a commercial (Bordier ELISA; Bordier Affinity Products SA) ELISA. We excluded: (i) samples with insufficient serum volume; (ii) samples from patients treated with ivermectin in the previous 6 months; and (iii) sera from patients for whom only routine coproparasitology was performed after formol-ether concentration, if negative for S. stercoralis larvae. The performance of the novel assays was assessed against: (i) a primary reference standard, with samples classified as negative/positive on the basis of the results of fecal tests; (ii) a composite reference standard (CRS), which also considered patients to be positive who had concordant positive results for the IFAT and Bordier ELISA or with a single "high titer" positive result for the IFAT or Bordier ELISA. Samples with a single positive test, either for the IFAT or Bordier ELISA, at low titer, were considered to be "indeterminate," and analyses were carried out with and without their inclusion. RESULTS: When assessed against the primary reference standard, the sensitivities of the IgG and IgG4 ELISAs were 92% (95% confidence interval [CI]: 88-97%) and 81% (95% CI: 74-87%), respectively, and the specificities were 91% (95% CI: 88-95%) and 94% (95% CI: 91-97%), respectively. When tested against the CRS, the IgG ELISA performed best, with 78% sensitivity (95% CI: 72-83%) and 98% specificity (95% CI: 96-100%), when a cut-off of 0.675 was applied and the indeterminate samples were excluded from the analysis. CONCLUSION: The NIE-SsIR IgG ELISA demonstrated better accuracy than the IgG4 assay and was deemed promising particularly for serosurveys in endemic areas.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos/genética , Ensayo de Inmunoadsorción Enzimática/métodos , Ensayo de Inmunoadsorción Enzimática/normas , Inmunoglobulina G/sangre , Strongyloides stercoralis/inmunología , Estrongiloidiasis/diagnóstico , Animales , Antígenos Helmínticos/inmunología , Preescolar , Reacciones Cruzadas , Humanos , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Estándares de Referencia , Reproducibilidad de los Resultados , Estudios Retrospectivos , Sensibilidad y Especificidad , Estrongiloidiasis/sangre , Estrongiloidiasis/inmunologíaRESUMEN
Strongyloides stercoralis affects more than half a billion people worldwide, and hyperinfection in immunocompromised patients can be fatal. Elimination of this neglected tropical disease requires field-applicable diagnostic tools. We conducted a laboratory evaluation of a lateral flow rapid dipstick test (SsRapid™) using sera samples from a Strongyloides-endemic area in northeast Thailand. Group 1 was S. stercoralis-positive and larvae- and/or antibody-positive (according to the IgG ELISA) (N = 100). Group 2 had negative fecal examination and IgG ELISA results (N = 25). Group 3 had other parasitic infections and negative IgG ELISA results (N = 25). The results showed good diagnostic sensitivity (82%) and excellent specificity (96%). Suggested improvements in the SsRapid™ test include increased diagnostic sensitivity and conversion to the more robust cassette format. Field studies should be performed as well.
Asunto(s)
Anticuerpos Antihelmínticos/inmunología , Inmunoglobulina G/inmunología , Strongyloides stercoralis/inmunología , Estrongiloidiasis/diagnóstico , Animales , Anticuerpos Antihelmínticos/sangre , Heces/parasitología , Proteínas del Helminto , Humanos , Proteínas Recombinantes , Sensibilidad y Especificidad , Pruebas Serológicas , Estrongiloidiasis/sangre , TailandiaRESUMEN
Several epidemiological and immunological studies indicate a reciprocal association between obesity/metabolic syndrome and helminth infections. Numerous studies demonstrated that obesity is concomitant with chronic low-grade inflammation, which is marked by vital changes in cellular composition and function of adipose tissue. However, the effect of helminth infection on the homeostatic milieu in obesity is not well-understood. To determine the relationship between Strongyloides stercoralis (Ss) infection and obesity, we examined an array of parameters linked with obesity both before and at 6 months following anthelmintic treatment. To this end, we measured serum levels of pancreatic hormones, incretins, adipokines and Type-1, Type-2, Type-17, and other proinflammatory cytokines in those with non-diabetic obesity with (INF) or without Ss infection (UN). In INF individuals, we evaluated the levels of these parameters at 6 months following anthelmintic treatment. INF individuals revealed significantly lower levels of insulin, glucagon, C-peptide, and GLP-1 and significantly elevated levels of GIP compared to UN individuals. INF individuals also showed significantly lower levels of Type-1, Type-17 and other pro-inflammatory cytokines and significantly increased levels of Type-2 and regulatory cytokines in comparison to UN individuals. Most of these changes were significantly reversed following anthelmintic treatment. Ss infection is associated with a significant alteration of pancreatic hormones, incretins, adipokines, and cytokines in obese individuals and its partial reversal following anthelmintic treatment. Our data offer a possible biological mechanism for the protective effect of Ss infection on obesity.
Asunto(s)
Obesidad , Strongyloides stercoralis , Estrongiloidiasis , Adipoquinas/sangre , Adipoquinas/inmunología , Adulto , Animales , Citocinas/sangre , Citocinas/inmunología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/sangre , Obesidad/etiología , Obesidad/inmunología , Strongyloides stercoralis/inmunología , Strongyloides stercoralis/metabolismo , Estrongiloidiasis/sangre , Estrongiloidiasis/complicaciones , Estrongiloidiasis/inmunología , Estrongiloidiasis/terapia , Células TH1/inmunología , Células TH1/metabolismo , Células Th17/inmunología , Células Th17/metabolismo , Células Th2/inmunología , Células Th2/metabolismoAsunto(s)
Productos Biológicos/uso terapéutico , Inmunoglobulina G/sangre , Estrongiloidiasis/epidemiología , Adulto , Anciano , Animales , Australia/epidemiología , Femenino , Hidradenitis Supurativa/tratamiento farmacológico , Humanos , Masculino , Persona de Mediana Edad , Psoriasis/tratamiento farmacológico , Estudios Seroepidemiológicos , Pruebas Serológicas , Strongyloides stercoralis/inmunología , Estrongiloidiasis/sangre , Adulto JovenRESUMEN
The present study is aimed at evaluating serological method using scFv anti-Strongyloides sp. and reporting the frequencies of the results with conventional parasitological technique (faeces) in elderly individuals. Among 112 elderly individuals (≥60 years of age), 14.28% were positive for at least one enteroparasite, with one individual positive for S. stercoralis. Sera were evaluated for the presence of anti-Strongyloides sp. antibodies using total or detergent fraction extracts of Strongyloides venezuelensis, which presented positivity rates of 19.64% and 10.71%, respectively. An anti-HSP60 single-chain variable fragment from Strongyloides sp. was used to detect parasite antigens, with 5.36% (6 individuals) of ELISA-positive individuals returning a positive result. While the serological test indicates previous or recent infection and may be limited by antigen purification, the anti-HSP60 method reflects the presence of Strongyloides sp. immune complexes and exhibits greater sensitivity and specificity. Our results demonstrate the variable occurrence of enteroparasites in elderly individuals residing in long-term nursing homes and validate a novel epidemiological tool to describe infection cases by Strongyloides sp.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Complejo Antígeno-Anticuerpo/sangre , Antígenos Helmínticos/sangre , Chaperonina 60/sangre , Anticuerpos de Cadena Única/sangre , Estrongiloidiasis/diagnóstico , Anciano , Anciano de 80 o más Años , Animales , Anticuerpos Antihelmínticos/inmunología , Antígenos Helmínticos/inmunología , Brasil , Chaperonina 60/inmunología , Heces/parasitología , Femenino , Hogares para Ancianos , Humanos , Masculino , Persona de Mediana Edad , Casas de Salud , Sensibilidad y Especificidad , Anticuerpos de Cadena Única/inmunología , Strongyloides/crecimiento & desarrollo , Strongyloides/inmunología , Strongyloides/patogenicidad , Estrongiloidiasis/sangre , Estrongiloidiasis/inmunología , Estrongiloidiasis/parasitologíaRESUMEN
BACKGROUND: Helminths and tuberculosis (TB) largely overlap at the population level. Whether helminth infections influence disease severity and bacterial burdens in TB is not well understood. METHODS: This study was conducted to examine the disease severity in a cohort of pulmonary TB (PTB) individuals with (Ss+) or without (Ss-) seropositivity for Strongyloides stercoralis infection. RESULTS: Ss+ was associated with increased risk of cavitation (odds ratio [OR], 4.54; 95% confidence interval [CI], 2.33-9.04; P < .0001) and bilateral lung involvement (OR, 5.97; 95% CI, 3.03-12.09; P < .0001) in PTB individuals. Ss+ was also associated with higher bacterial burdens (OR, 7.57; 95% CI, 4.18-14.05; P < .0001) in PTB individuals. After multivariate analysis adjusting for covariates, Ss+ was still associated with greater risk of cavitation (adjusted OR [aOR], 3.99; 95% CI, 1.73-9.19; P = .0014), bilateral lung involvement (aOR, 4.09; 95% CI, 1.78-9.41; P = .0011), and higher bacterial burden (aOR, 9.32; 95% CI, 6.30-13.96; P < .0001). Finally, Ss+ was also associated with higher plasma levels of matrix metalloproteinases ([MMP]-1, -2, -7, -8, and -9) in PTB individuals. CONCLUSIONS: Therefore, our data demonstrate that coexistent Ss infection is associated with greater disease severity and higher bacterial burden in PTB. Our data also demonstrate enhanced plasma levels of MMPs in coinfected individuals, suggesting a plausible biological mechanism for these effects.
Asunto(s)
Coinfección , Metaloproteinasas de la Matriz/sangre , Strongyloides stercoralis , Estrongiloidiasis/sangre , Estrongiloidiasis/parasitología , Tuberculosis Pulmonar , Tuberculosis/sangre , Tuberculosis/microbiología , Adolescente , Adulto , Anciano , Animales , Biomarcadores , Femenino , Humanos , India/epidemiología , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Estrongiloidiasis/diagnóstico , Estrongiloidiasis/epidemiología , Tuberculosis/diagnóstico , Tuberculosis/epidemiología , Adulto JovenRESUMEN
OBJECTIVES: To evaluate co-infection of Strongyloides stercoralis and Trypanosoma cruzi and to assess eosinophilia as a screening test for the detection of S. stercoralis infection in patients with Chagas disease (CD). METHODS: A retrospective diagnostic validation study was performed on serum samples from primary care patients diagnosed with CD in the southern Barcelona metropolitan area. All samples with eosinophilia (n = 87) and a random sample of non-eosinophilic sera (n = 180) were selected. Diagnosis of CD was based on positive serology by means of two tests: ORTHO® T. cruzi ELISA test, and BIO-FLASH® Chagas or Bioelisa CHAGAS. SCIMEDX ELISA STRONGY-96 was used to diagnose strongyloidiasis. RESULTS: Strongyloides stercoralis serology was positive in 15% of patients of whom 95% showed eosinophilia, vs. 21% of those with negative serology (P < 0.001), with differences in the mean eosinophil count (0.49 vs. 0.27 × 109 /l). Only 1.1% of patients with CD but without eosinophilia presented positive serology for S. stercoralis, whereas 44% of patients with CD and eosinophilia did (P < 0.001). Sensitivity and specificity values for eosinophilia were thus 95% and 79%, respectively. PPV was 42.5% and NPV, 98.9%. CONCLUSIONS: The prevalence of co-infection by T. cruzi and S. stercoralis is not negligible and has probably been underestimated for years in many areas, due to frequently subclinical infections. Therefore, serology seems mandatory for these patients and the use of eosinophilia as initial screening could facilitate the task, decreasing the number of analyses to be performed.
OBJECTIFS: Evaluer la coinfection par Strongyloides stercoralis et Trypanosoma cruzi et évaluer éosinophilie comme un test de dépistage pour la détection de l'infection à S. stercoralis chez les patients atteints de la maladie de Chagas (MC). MÉTHODES: Une étude de validation diagnostique rétrospective a été réalisée sur des échantillons de sérum de patients de soins primaires diagnostiqués avec la MC dans la région métropolitaine du sud de Barcelone. Tous les échantillons avec éosinophilie (n = 87) et un échantillon aléatoire de sérums non éosinophiliques (n = 180) ont été sélectionnés. Le diagnostic de la MC était basé sur une sérologie positive au moyen de deux tests: le test ELISA ORTHO® T. cruzi et le test BIO-FLASH® Chagas ou Bioelisa CHAGAS. SCIMEDX ELISA STRONGY-96 a été utilisé pour diagnostiquer la strongyloïdose. RÉSULTATS: La sérologie de S. stercoralis était positive chez 15% des patients dont 95% présentaient une éosinophilie, contre 21% de ceux avec une sérologie négative (P <0,001), avec des différences dans le taux moyen d'éosinophiles (0,49 contre 0,27 × 109 /L). Seuls 1,1% des patients avec la MC mais sans éosinophilie présentaient une sérologie positive pour S. stercoralis ; contrairement à 44% des patients atteints de la MC avec une éosinophilie (p <0,001). Les valeurs de sensibilité et de spécificité pour l'éosinophilie étaient ainsi respectivement de 95% et 79%. La VPP était de 42,5% et la VPN, 98,9%. CONCLUSIONS: La prévalence de la coinfection par T. cruzi et S. stercoralis n'est pas négligeable et a probablement été sous-estimée depuis des années dans de nombreuses régions, en raison d'infections fréquemment infracliniques. Par conséquent, la sérologie semble obligatoire pour ces patients et l'utilisation de l'éosinophilie comme dépistage initial pourrait faciliter la tâche, diminuant le nombre d'analyses à effectuer.
Asunto(s)
Enfermedad de Chagas , Pruebas Diagnósticas de Rutina , Emigrantes e Inmigrantes , Strongyloides stercoralis , Estrongiloidiasis/epidemiología , Adolescente , Adulto , Anciano , Animales , Anticuerpos Antihelmínticos/sangre , Eosinofilia/sangre , Femenino , Humanos , América Latina/etnología , Masculino , Persona de Mediana Edad , Prevalencia , Atención Primaria de Salud , Reproducibilidad de los Resultados , Estudios Retrospectivos , España/epidemiología , Strongyloides stercoralis/inmunología , Estrongiloidiasis/sangre , Estrongiloidiasis/diagnóstico , Adulto JovenRESUMEN
OBJECTIVES: Hyperinfection or disseminated strongyloidiasis has been frequently reported after transplants and is related to high mortality. This study aimed to screen for strongyloidiasis using serological diagnoses in transplant candidates. METHODS: An ELISA test was performed with filariform larvae of Strongyloides venezuelensis as a source of antigen. RESULTS: In the serum from transplant candidates, anti-Strongyloides IgG antibodies were detected in 35/150 (23.3%) samples by soluble fractions in phosphate buffered saline (PBS), 31/150 (20.7%) samples by soluble fractions in Tris-HCl, 27/150 (18.0%) samples by membrane fractions in PBS and 22/150 (14.7%) samples by membrane fractions in Tris-HCl. CONCLUSIONS: The present results suggest the ELISA test, ideally using soluble fractions of filariform larvae S. venezuelensis in PBS, as an additional strategy for the diagnosis of strongyloidiasis in transplant candidates.
Asunto(s)
Antígenos Helmínticos/inmunología , Inmunoglobulina G/sangre , Trasplante de Órganos , Strongyloides stercoralis/inmunología , Estrongiloidiasis/diagnóstico , Adolescente , Adulto , Animales , Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos/aislamiento & purificación , Biomarcadores/sangre , Niño , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Huésped Inmunocomprometido , Masculino , Tamizaje Masivo , Persona de Mediana Edad , Sensibilidad y Especificidad , Estrongiloidiasis/sangre , Estrongiloidiasis/parasitología , Adulto JovenRESUMEN
BACKGROUND: Strongyloides stercoralis infection is a neglected tropical disease with global distribution which is fatal in immunosuppressed patients. This study aimed to determine the prevalence of strongyloidiasis in immunocompromised individuals and cases with infectious diseases, as well as comparing ELISA and conventional PCR with coprological examination, in the central parts of Mazandaran province, northern Iran. METHODS: A single serum and a fresh stool samples were obtained from 272 and 220 patients, respectively. Serum was tested by ELISA and PCR of the 18S rRNA gene, and stool samples were examined with various parasitological methods. The optimum point for ELISA reaction and cut-off points were recognized by receiver operating characteristic curves (ROC). RESULTS: Out of 220 stool specimens, 14(6.3%) cases were positive for S. stercoralis larvae. The overall seroprevalence rate was 27.9% (76/272). The seroprevalence rate was 25.2% and 30.1% in immunocompromised group and patients with infection, respectively. Based on the ROC curve of ELISA compared with microscopy, the optimum cut-off point was 12.74 with 79% sensitivity and 76% specificity. The optimum cut-off point was 10.42 with 69% sensitivity and specificity using ROC curve of ELISA compared with PCR. CONCLUSIONS: This study seroprevalence rate for Strongyloides infection in the studied group. It also observed that the ELISA technique and the PCR used here have 100 demonstrated a high % sensitivity and acceptable specificity compared with coprological examination. It seems that the ELISA technique is a good screening assay in ruling out strongyloidiasis in such patients.
Asunto(s)
Ensayo de Inmunoadsorción Enzimática , ARN Ribosómico 18S/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Estrongiloidiasis/sangre , Estrongiloidiasis/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Animales , Heces/parasitología , Femenino , Genes de ARNr , Humanos , Huésped Inmunocomprometido , Irán/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Curva ROC , Sensibilidad y Especificidad , Estudios Seroepidemiológicos , Strongyloides stercoralis/genética , Estrongiloidiasis/epidemiología , Adulto JovenRESUMEN
Strongyloides stercoralis can cause disease that ranges from asymptomatic chronic infection to fatal hyperinfection. Diagnosis from stool can be challenging because the most sensitive conventional tests require live larvae to be effective and there can be low larval output in chronic infection. Nucleic acid amplification tests (NAAT) have been developed to complement existing diagnostic methods. We compared a recently developed loop-mediated isothermal amplification (LAMP) assay with a real-time PCR that has previously been validated with larval microscopy. The limits of detection-quantified using serial dilutions of DNA extracts from single Strongyloides ratti third-stage (L3) larvae spiked into approximately 250 µl of 5 different S. stercoralis-negative stool specimens-were 10-3 (1/5 replicates) and 10-2 (1/5 replicates) dilutions for PCR and LAMP, respectively. PCR was positive for 4/5 replicates at 10-2 LAMP was compared to PCR using extracts from 396 stool specimens collected in Bangladesh and Australia, of which 53 were positive and 343 were negative by PCR. The positive percentage agreement of LAMP was 77.3% (95% score confidence interval [CI], 64.5 to 86.6). The negative percentage agreement was 100% (95% CI, 98.9 to 100). In a preliminary investigation, PCR and LAMP assays were positive using DNA extracted from serum (PCR, 3/16 extracts; LAMP, 2/16 extracts) and bronchoalveolar lavage fluid (PCR and LAMP, 2/2 extracts), demonstrating proof of concept. Compared to PCR, the lower number of positive results using the LAMP assay may have been due to reaction inhibitors and DNA degradation, and strategies to improve the LAMP assay are discussed.
Asunto(s)
Técnicas de Amplificación de Ácido Nucleico/normas , Reacción en Cadena en Tiempo Real de la Polimerasa/normas , Strongyloides stercoralis/aislamiento & purificación , Estrongiloidiasis/diagnóstico , Anciano , Animales , Australia , Bangladesh , Líquido del Lavado Bronquioalveolar/parasitología , Cartilla de ADN/genética , ADN de Helmintos/aislamiento & purificación , Heces/parasitología , Humanos , Larva , Límite de Detección , Masculino , Persona de Mediana Edad , Técnicas de Amplificación de Ácido Nucleico/métodos , Reacción en Cadena en Tiempo Real de la Polimerasa/métodos , Sensibilidad y Especificidad , Estrongiloidiasis/sangreRESUMEN
BACKGROUND: Global migration from regions where strongyloidiasis and schistosomiasis are endemic to non-endemic countries has increased the potential individual and public health effect of these parasitic diseases. We aimed to estimate the prevalence of these infections among migrants to establish which groups are at highest risk and who could benefit from screening. METHODS: We did a systematic review and meta-analysis of strongyloidiasis and schistosomiasis prevalence among migrants born in endemic countries. Original studies that included data for the prevalence of Strongyloides or Schistosoma antibodies in serum or the prevalence of larvae or eggs in stool or urine samples among migrants originating from countries endemic for these parasites and arriving or living in host countries with low endemicity-specifically the USA, Canada, Australia, New Zealand, Israel, and 23 western European countries-were eligible for inclusion. Pooled estimates of the prevalence of strongyloidiasis and schistosomiasis by stool or urine microscopy for larvae or eggs or serum antibodies were calculated with a random-effects model. Heterogeneity was explored by stratification by age, region of origin, migrant class, period of study, and type of serological antigen used. FINDINGS: 88 studies were included. Pooled strongyloidiasis seroprevalence was 12·2% (95% CI 9·0-15·9%; I2 96%) and stool-based prevalence was 1·8% (1·2-2·6%; 98%). Migrants from east Asia and the Pacific (17·3% [95% CI 4·1-37·0]), sub-Saharan Africa (14·6% [7·1-24·2]), and Latin America and the Caribbean (11·4% [7·8-15·7]) had the highest seroprevalence. Pooled schistosomiasis seroprevalence was 18·4% (95% CI 13·1-24·5; I2 97%) and stool-based prevalence was 0·9% (0·2-1·9; 99%). Sub-Saharan African migrants had the highest seroprevalence (24·1·% [95% CI 16·4-32·7]). INTERPRETATION: Strongyloidiasis affects migrants from all global regions, whereas schistosomiasis is focused in specific regions and most common among sub-Saharan African migrants. Serological prevalence estimates were several times higher than stool estimates for both parasites. These data can be used to inform screening decisions for migrants and support the use of serological screening, which is more sensitive and easier than stool testing. FUNDING: None.
Asunto(s)
Emigrantes e Inmigrantes/estadística & datos numéricos , Esquistosomiasis/epidemiología , Estrongiloidiasis/epidemiología , África del Sur del Sahara/etnología , Australia/epidemiología , Canadá/epidemiología , Región del Caribe/etnología , Enfermedades Endémicas , Europa (Continente)/epidemiología , Asia Oriental/etnología , Heces/parasitología , Humanos , Israel/epidemiología , América Latina/etnología , Tamizaje Masivo , Nueva Zelanda/epidemiología , Islas del Pacífico/etnología , Prevalencia , Esquistosomiasis/sangre , Esquistosomiasis/diagnóstico , Esquistosomiasis/orina , Estudios Seroepidemiológicos , Pruebas Serológicas , Estrongiloidiasis/sangre , Estrongiloidiasis/diagnóstico , Estrongiloidiasis/orina , Estados Unidos/epidemiologíaRESUMEN
BACKGROUND: The association between diabetes and Strongyloides stercoralis remains controversial. We conducted a case-control study examining the association between diabetes and Strongyloides seropositivity in a large UK centre. METHODS: Between January 2013 and October 2016, cases and controls were identified by positive and negative Strongyloides serology, respectively. Demographic, clinical and microbiological data were retrospectively collected. Multivariate logistic regression analysis was performed. RESULTS: Over the study period, 532 samples were serologically tested for Strongyloides. After exclusion of duplicates and cases with missing data, 100 (22.3%; 95% CI 18.5-26.4%) out of 449 tested positive. Of seropositive cases, the mean age was 57 years (SD 16), 71 (71%) were male, 94 (94%) were migrants and 92 (92%) had eosinophilia.Univariate logistic regression analysis demonstrated a significant association between Strongyloides seropositivity and age (OR 1.04, 95% CI 1.02-1.05), male sex (OR 2.22, 95% CI 1.37-3.59), migration (OR 5.36, 95% CI 2.27-12.67), eosinophilia (OR 4.36, 95% CI 2.04-9.33) and diabetes (OR 3.52, 95% CI 2.19-5.66). In multivariate analysis, there remained a significant association between diabetes and Strongyloides seropositivity (OR 1.81, 95% CI 1.04-3.16). CONCLUSIONS: We demonstrated a high rate of Strongyloides seropositivity in our East London cohort and a significant association with diabetes.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Complicaciones de la Diabetes/parasitología , Estudios Seroepidemiológicos , Estrongiloidiasis/sangre , Estrongiloidiasis/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Estudios de Cohortes , Femenino , Humanos , Londres/epidemiología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Prevalencia , Estudios Retrospectivos , Estrongiloidiasis/epidemiología , Adulto JovenRESUMEN
Immunocompromised patients constitute a risk group for the development of severe clinical forms of human strongyloidiasis. The diagnosis of this infection is primarily performed by parasitological techniques, but with low sensitivity. Serological techniques appear as an alternative, especially with heterologous antigens use. The aim of this study was to perform the Western blot technique by using S. venezuelensis infective third stage larva (iL3) soluble (TS) and membrane (TM) saline antigens to reveal immunoreactive bands in immunocompromised patients with strongyloidiasis. Serum samples from 117 parasitologically well-characterized patients were divided into four groups: S. stercoralis positive and immunocompetent (S + IC); S. stercoralis positive and immunocompromised (S + IP); negative and immunocompetent (S-IC); negative and immunocompromised (S-IP). A 40-35 kDa band was recognized by 100% of patients in the S + IC group in both antigenic fractions, and by 62.5% and 50% in the S + IP group using the TS and TM fractions, respectively. A 29 kDa band was recognized by 86.3% and 72.7% (for TS and TM, respectively) of patients in the S + IC group, and only by 12.5% of patients in the S + IP group on the TM antigen. Regardless of the patients' immunological condition, the 40-35 kDa band from S. venezuelensis was detected more frequently and can be used as an important marker to the immunodiagnosis of human strongyloidiasis.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Antígenos Helmínticos/inmunología , Inmunoglobulina G/sangre , Strongyloides stercoralis/inmunología , Estrongiloidiasis/diagnóstico , Animales , Biomarcadores/sangre , Western Blotting , Humanos , Huésped Inmunocomprometido , Larva/inmunología , Pruebas Serológicas , Estrongiloidiasis/sangreRESUMEN
Central nervous system (CNS) strongyloidiasis is a known but rare form of disseminated infection. The diagnosis is often made postmortem, with only five published cases of an antemortem diagnosis. We report two fatal cases of CNS strongyloidiasis diagnosed antemortem, with Strongyloides stercoralis larvae visualized in the CNS sample in one case. Risk factors for disseminated strongyloidiasis common to both cases included origination from the Caribbean, underlying human T-lymphotropic virus-1 infection, and recent prednisone use. Both cases occurred in Canada, where the occurrence of Strongyloides is uncommon, and serve as a reminder to maintain a high index of suspicion in patients with epidemiologic or clinical risk factors for dissemination.
Asunto(s)
Sistema Nervioso Central/parasitología , Diagnóstico , Strongyloides stercoralis/aislamiento & purificación , Estrongiloidiasis/diagnóstico , Anciano , Animales , Canadá , Región del Caribe , Resultado Fatal , Femenino , Infecciones por HTLV-I/complicaciones , Humanos , Masculino , Persona de Mediana Edad , Prednisona/efectos adversos , Factores de Riesgo , Estrongiloidiasis/sangreRESUMEN
In dogs, information on treatments against S. stercoralis infection is rare and anecdotal. The aim of the present work was to evaluate the treatment outcome of S. stercoralis natural infection in sheltered dogs. Furthermore, based on the potential risk of infection, people working in the infected shelter were also tested. Seventeen sheltered dogs positive to S. stercoralis using the Baermann test were treated with ivermectin 200 µg/kg/sid/os for two consecutive days. Only two dogs showed clinical signs suggestive of strongyloidiasis (diarrhea, weigh loss) at diagnosis. All dogs showed consistently negative results for S. stercoralis at weekly monitoring after treatment using both the direct microscopy and Baermann test. Real-time PCR confirmed negative results at the last follow up 2 months after treatment. Serology performed at the first diagnosis showed that 82% and 41% of dogs were positive for S. stercoralis using an IFAT (titres ranging from 1:40 to 1:320) and ELISA, respectively. Two months after treatment, IFAT titres were strongly reduced in all animals. The results of clinical pathological laboratory tests at diagnosis in the positive dogs were within normal ranges, except for the two symptomatic dogs. Serum collected from two out of 14 shelter workers tested positive with titres 1:20 and 1:40 for S. stercoralis using an IFAT. Results of the study confirm that ivermectin was an effective treatment option to control S. stercoralis infection in dogs. Shelter workers are at risk of infection with S. stercoralis, thus the application of correct deworming protocols to reduce the environmental infective larval burden is essential to protect dogs and probably also shelter workers from the risk of infection.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Antiparasitarios/uso terapéutico , Ivermectina/uso terapéutico , Enfermedades Profesionales/sangre , Strongyloides stercoralis/inmunología , Estrongiloidiasis/veterinaria , Animales , ADN/sangre , Perros , Femenino , Humanos , Masculino , Strongyloides stercoralis/genética , Estrongiloidiasis/sangre , Estrongiloidiasis/diagnóstico , Estrongiloidiasis/tratamiento farmacológico , Resultado del TratamientoRESUMEN
To evaluate the accuracy and reliability of urine assay for the diagnosis of strongyloidiasis, three different immunoassays were used to assess the diagnostic accuracy of anti-Strongyloides immunoglobulin G (IgG) in urine and compared with those in serum samples. Analyses by InBios enzyme-linked immunosorbent assay (ELISA) kit (recombinant NIE antigen), SciMedx ELISA kit (Strongyloides stercoralis antigen), and our in-house ELISA (Strongyloides ratti antigen) yielded comparable diagnostic performances between urine and serum assays. Levels of Strongyloides-specific IgG in urine significantly correlated with those in serum. Tests for diagnostic agreement between urine and serum IgG assays showed substantial to fair agreement (κ = 0.207-0.615). The observed quantitative and qualitative concordance between urine and serum assays in strongyloidiasis suggests that urine has similar diagnostic value to that for serum. Because of the ease and noninvasiveness of clinical sample collection, urine assay has a high potential for the initial diagnosis and mass screening of strongyloidiasis.
Asunto(s)
Anticuerpos Antihelmínticos/sangre , Anticuerpos Antihelmínticos/orina , Ensayo de Inmunoadsorción Enzimática/normas , Inmunoglobulina G/sangre , Inmunoglobulina G/orina , Strongyloides stercoralis/aislamiento & purificación , Estrongiloidiasis/diagnóstico , Anciano , Animales , Estudios Transversales , Ensayo de Inmunoadsorción Enzimática/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Reproducibilidad de los Resultados , Strongyloides stercoralis/inmunología , Estrongiloidiasis/sangre , Estrongiloidiasis/orinaRESUMEN
BACKGROUND: Strongyloides stercoralis is a worldwide disseminated parasitic disease that can be transmitted from solid organ transplant (SOT) donors to recipients. We determined the serological prevalence of S. stercoralis among deceased individuals from endemic areas considered for SOT donation, using our institution's serum bank. METHODOLOGY: Retrospective study including all deceased potential donors from endemic areas of strongyloidiasis considered for SOT between January 2004 and December 2014 in a tertiary care hospital. The commercial serological test IVD-Elisa was used to determine the serological prevalence of S. stercoralis. PRINCIPAL FINDINGS: Among 1025 deceased individuals during the study period, 90 were from endemic areas of strongyloidiasis. There were available serum samples for 65 patients and 6 of them tested positive for S. stercoralis (9.23%). Only one of the deceased candidates was finally a donor, without transmitting the infection. CONCLUSIONS: Among deceased individuals from endemic areas considered for SOT donation, seroprevalence of strongyloidiasis was high. This highlights the importance of adhering to current recommendations on screening for S. stercoralis among potential SOT donors at high risk of the infection, together with the need of developing a rapid diagnostic test to fully implement these screening strategies.